CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 95 enrolled
Drug / intervention
Nicotine Replacement Therapy +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05030766
NCT05030766Phase 4Completed

A Pilot SMART Pre- and Post-testing of an Integrative Mindfulness-Based Smoking Cessation Intervention for HIV Patients

University of Miami·interventional·Posted Sep 1, 2021·Updated Jun 4, 2025

In Brief

A Phase 4 clinical trial evaluating Nicotine Replacement Therapy, Mindfulness Training Smoking Cessation Intervention, and 1 other intervention for Smoking and 2 related conditions. Completed, enrolled 95 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedSep 1, 2021
Enrollment StartJan 4, 2022
Primary CompletionMay 23, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.8 years ago

Interventions

Nicotine Replacement Therapydrug

6 weeks of Nicotine replacement patches

Mindfulness Training Smoking Cessation Interventionbehavioral

Mindfulness Training Smoking Cessation Intervention administered online via Zoom. Each session lasts 60-90 minutes, twice weekly for 4 weeks for a total of 8 sessions.

Contingency Management Smoking Cessation Interventionbehavioral

Contingency Management Smoking Cessation Intervention includes one orientation session lasting about 60-90 minutes administered via Zoom. Participants will then be required to contact the research associate about their quitting progress three times a week for 4 weeks also by zoom.